Since 2022, many type 2 diabetes and weight-loss injectables (including, but not limited to Wegovy, Mounjaro, Ozempic, Saxenda, and Zepbound) have been on a national shortage. We have received a surge of phone calls in the past months from concerned patients and providers seeking to find a medication they cannot abruptly stop, or from patients looking to start new therapies. As an independent pharmacy who strives to help our community navigate through healthcare challenges, we wanted to find alternatives that support our patients’ goals.
Lititz Apothecary has received all approvals during this back-order period and has developed two programs which includes an Injectable Semaglutide and Terzepatide (Mounjaro and Zepbound) and a Troche (lozenge) with the same active ingredients as Wegovy and Ozempic.
Cost:
o Sublingual Troche: Starting at $250 per month.
o Injectable: Starting at $350 every 4 weeks
Overall Process:
Once you complete this form, an onboarding specialist will reach out and go over the details.
1. You may reach out to your Provider (doctor's office) AND the pharmacy will reach out to the provider as well (advocating on your behalf)
2. Once the prescription is received, we will contact you to set a time with a clinician to go over injection techniques, best practices, and other FAQ.
3. When you are due for a refill, our staff will contact you, 3-5 days in advance to go over your progress and prepare the next month's dosage.